Here is the latest stock price and chart of EP BIOCOMPOSITES. For more details, see the EP BIOCOMPOSITES company fact sheet and quarterly results.
Alert: A Powerful Small Cap Trend is Unfolding in India
Live BSE Quotes | May 22, 2024 01:29:00 PM | ||
---|---|---|---|
Price (Rs)138.00 | Open (Rs) 138.00 | High (Rs) 138.00 | Low (Rs) 138.00 |
% Change2.26 | Volume 500 | Value (Rs) 69,000 | 52-Week H/L 254.00 / 122.00 |
Live NSE Quotes |
---|
Not listed |
Change | |||||
---|---|---|---|---|---|
1 Day 2.26% | 1 Month -1.78% | 3 Months -22.69% | 1 Year -28.77% |
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* - | P/E Ratio (x) - | Market Cap (Rs m) 232.05 | P/BV (x) 2.70 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
EP BIOCOMPOSITES last traded price was up 2.3% to Rs 138.0 on the BSE. The total volume of shares traded was 0.0 m.
Overall, the benchmark S&P BSE SENSEX was at 74,119.2 (up 0.2%).
Over the last 30 days, the EP BIOCOMPOSITES share price is down 7.9%. And over the last one year, EP BIOCOMPOSITES share price is down 35.5%.
The current market capitalisation of EP BIOCOMPOSITES stands at Rs 232.05 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2024, company promoters held 70.08% stake in EP BIOCOMPOSITES, with no shares having been pledged. To know more, check out the latest shareholding pattern of EP BIOCOMPOSITES.
Before you go, here's an alert on EP BIOCOMPOSITES you may want to take note of...
Date | Announcement | Ex-Date |
---|---|---|
24-May-2024 | Quarterly Results | - |
List of All Upcoming Corporate Actions
The last traded price of EP BIOCOMPOSITES was Rs 138.0 on the BSE, up 2.3% over the previous close.
The current market capitalisation of EP BIOCOMPOSITES stands at Rs 232 m.
Asian shares edged higher on Wednesday as anxious investors dared to hope AI-diva Nvidia could meet sky-high expectations, while keeping a wary eye on the outlook for US and UK interest rates.